Analysis of efficacy of Losartan and HCTZ combo on hypertension in connective tissue diseases

Analysis of efficacy of Losartan and HCTZ combo on hypertension in connective tissue diseases - Analysis of efficacy of Losartan and HCTZ combo on hypertension in connective tissue diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002028

Enrollment

100

Registered

2009-07-31

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Collagen disease patients with hypertension

Interventions

connective tissue disease patients with hypertensin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Blood pressure of the connective tissue disease patient with hypertension shows the SBP140 mmHg/ DBP90 mmHg above. Or the patients want to decrase the number of drug.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
change of SBP and DBP in connective tissue disease patients	—

Secondary

Measure	Time frame
change of SBP and DBP in general practice patients	—

Countries

Japan

Contacts

Public ContactKeisuke Hagihara

Osaka University Graduate School of Medicine Department of Respiratory Medicine, Allergy, and Rheumatic Diseases

06-6879-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026